Anavex Life Sciences Corp (AVXL)

[nidan7500]

“The ILAP designation represents a clear signal of regulatory support for a prospective treatment breakthrough in Alzheimer’s, which remains one of the world’s greatest unmet medical needs. Dementia is a leading cause of death around the world, and the Innovation Passport, as the first stage of the ILAP scheme, enables access to the collaborative approach of regulators and associated health technology assessment bodies to both drug licensing and access throughout the UK,” Wischik said.

https://alzheimersnewstoday.com/2022/06/06/alzheimers-tau-targeting-therapy-slows-cognition-functional-drops-trial/?utm_source=ALZ&utm_campaign=c066876eda-ALZ_ENL_3.0_US&utm_medium=email&utm_term=0_94425accb7-c066876eda-71515993

When will this statement (LEADING CAUSE OF DEATH) be internalized and acted on WW? It is not inevitable. Looking for more HC System urgency.